Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma

被引：1
|
作者：
Fozza, Claudio [1 ]
Galleu, Antonio [1 ]
Careddu, Maria Grazia [1 ]
Giannico, Domenica Barbara [1 ]
Bonfigli, Silvana [1 ]
Contini, Salvatore [1 ]
Longinotti, Maurizio [1 ]
机构：
[1] Univ Sassari, Inst Haematol, I-07100 Sassari, Italy
来源：
ANNALS OF HEMATOLOGY | 2010年 / 89卷 / 01期
关键词：
Chronic Lymphocytic Leukemia; Autoimmune Hemolytic Anemia; Kappa Light Chain; Macrocytic Anemia; Bone Marrow Smear;
D O I：
10.1007/s00277-009-0782-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 114
页数：2
相关论文
共 50 条
  • [1] Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma
    Claudio Fozza
    Antonio Galleu
    Maria Grazia Careddu
    Domenica Barbara Giannico
    Silvana Bonfigli
    Salvatore Contini
    Maurizio Longinotti
    Annals of Hematology, 2010, 89 : 113 - 114
  • [2] SPLENIC MARGINAL ZONE LYMPHOMA FLOWS WITH AUTOIMMUNE HEMOLYTIC ANEMIA
    Julhakyan, H.
    Magomedova, A.
    Kaplanskaya, I.
    Tsvetaeva, N.
    HAEMATOLOGICA, 2012, 97 : 657 - 657
  • [3] Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma
    Oladiran, Oreoluwa
    Dhital, Rashmi
    Donato, Anthony
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2018, 8 (04): : 244 - 245
  • [4] Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia
    Fabbri, Alberto
    Gozzetti, Alessandro
    Lazzi, Stefano
    Lenoci, Mariapia
    D'Amuri, Alessandro
    Leoncini, Lorenzo
    Lauria, Francesco
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06): : 496 - 499
  • [5] No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Sachanas, Sotirios
    Rontogianni, Demetra
    Korkolopoulou, Penelope
    Milionis, Vassilis
    Vassilakopoulos, Theodoros P.
    Papadaki, Helen A.
    Angelopoulou, Maria K.
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2705 - 2708
  • [6] Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase
    Paydas, S
    Yavuz, S
    Disel, U
    Sahin, B
    Ergin, M
    LEUKEMIA & LYMPHOMA, 2003, 44 (12) : 2165 - 2166
  • [7] Persistent Autoimmune Hemolytic Anemia Complicating Splenic Marginal Zone Lymphoma: A Case Report
    Taalab, Mona
    El Menshawy, Nadia
    Khalifa, Raghda
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S493 - S493
  • [8] High frequency and prognostic importance of autoimmune hemolytic anemia in splenic marginal zone lymphoma
    Fodor, A.
    Hoffer, I.
    Krenacs, L.
    Bagdi, E.
    Csomor, J.
    Matolcsy, A.
    Molnar, M. Z.
    Eid, H.
    Nagy, Z.
    Demeter, J.
    EJC SUPPLEMENTS, 2010, 8 (04): : 23 - 23
  • [9] Repertoire of IgVH Genes in Splenic Marginal Zone Lymphoma Complicated with Autoimmune Hemolytic Anemia
    Julhakyan, Hunan
    Biderman, Bella
    Tsvetaeva, Nina
    Al-Radi, Lyubov
    Moiseeva, Tatyana
    Savenko, Tatyana
    Gribanova, Elena
    Melikyan, Anait
    Sudarikov, Andrey
    Savchenko, Valeriy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S391 - S391
  • [10] Autoimmune Hemolytic Anemia as a Risk Factor of Poor Outcome in Patients with Splenic Marginal Zone Lymphoma
    Fodor, Aniko
    Molnar, Miklos Zsolt
    Krenacs, Laszlo
    Bagdi, Eniko
    Csomor, Judit
    Matolcsy, Andras
    Demeter, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (04) : 597 - 603
12345